Danielle Boyle: ITP Australia and New Zealand Patient Conference to Connect Patients, Families, and Experts
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, reposted from ITP Australia and New Zealand on LinkedIn:
”The annual ITP Australia and New Zealand Patient Conference is the anchor of our calendar, and it’s hard to believe we’re now less than a month away.
This year, we’ll gather at Melbourne Town Hall on Saturday, 7 March 2026, joined by an exceptional group of medical and scientific leaders who are deeply committed to advancing care and understanding for people living with Immune Thrombocytopenia.
What stays with me every year is the collective Exhale from patients and families as they realise they’re surrounded by people who genuinely understand their journey.
It’s a moment of recognition, relief, and connection — a reminder that no one has to navigate ITP alone.
We warmly welcome our industry partners, healthcare professionals, researchers, and anyone with an interest in ITP to join us.
It’s an opportunity to hear directly from the community, understand the questions that matter most to patients, and experience the impact of bringing lived experience and clinical expertise together.
Grab your tickets today.”
Quoting ITP Australia and New Zealand‘s post:
”One month until the ITPANZ Annual Patient Conference in Melbourne.
This event brings together patients, families, clinicians, and researchers for a day of education, discussion, and shared insight into Immune Thrombocytopenia.
The program includes expert presentations, treatment updates, and lived‑experience perspectives designed to support informed, patient‑centred care.
Stay updated with Hemostasis Today.
-
Oct 4, 2026, 01:13Francesc Formiga: Updated Evidence on LAA Closure Versus Oral Anticoagulation in AF
-
Oct 4, 2026, 01:11Alicja Urbaniak: Targeting CD148 to Develop New Antithrombotic Therapies
-
Oct 4, 2026, 01:03Susan Mou: Presenting Long-Term Clinical Outcomes in SCD and TDT
-
Oct 4, 2026, 01:00Mark Johnson: Elevating Patient and Warrior Voices During Sickle Cell Awareness Month
-
Oct 4, 2026, 00:55Pier Maria Fornasari: Possible New Target for SCD and Beta Thalassemia Treatment
-
Oct 4, 2026, 00:48Sthanu Subramanian: Mechanisms, Clinical Phenotypes, Imaging, and Treatment of CVT
-
Oct 4, 2026, 00:33Ashish Pemawat: Can We Protect the Brain while We Restore Blood Flow?
-
Oct 4, 2026, 00:32Marta Nowakowska-Kotas: Could a Small Rise in Creatinine after Thrombectomy in Stroke Patients Be an Early Warning Sign?
-
Oct 4, 2026, 00:26Mohammad Nafeli Shahrestani: CXCL10 Associated With Increased Long-Term Risk of Ischemic Stroke